H
HELP
Helus Pharma Inc
11.80
+1.08+10.07%After Hours: 11.95 +0.15 +1.27%19:59 10/09 EDT
OPEN/PREV CLOSE11.78/11.80
TODAY RANGE11.00-12.73
VOL2.53K
MARKET CAP805.85M
52 WEEK RANGE3.760-15.15
AVG VOL (3M)1.78M
% TURNOVER3.10%
TURNOVER0
P/E (TTM)-2.5951
% RANGE14.53%
EPS(TTM)-4.2503
P/E(FORWARD)-4.1877
P/B2.824
BVPS3.906
DIVIDEND--
P/S46.38
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP619.45M
SHARES OUTSTANDING73.06M
NEXT EARNINGS11/11-11/16
FREE FLOAT56.16M
LOT SIZE1
EX-DATE09/19/2024
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Helus Pharma: A Buy Ahead Of The HLP003 Phase 3 Readout
TipRanks·10/05 15:26
Helus Pharma Files October Form 6-K and Corporate Amendment with U.S. SEC
TipRanks·10/05 13:55
Jefferies Sticks to Their Buy Rating for Helus Pharma (HELP)
TipRanks·10/03 13:00
Dynex, Hershey, Helus, Hyperscale Data, Gap Inc Insider Shake-Up
TipRanks·10/01 14:30
Psychedelic: Psyence BioMed announces exclusive U.S. ibogaine license
TipRanks·10/01 13:21
Helus Pharma Finalizes Legal Name Change as It Prepares for Commercial Push
TipRanks·09/26 13:01
Nutanix, Star Bulk, Lennar, Hershey, Helus Insider Shock
TipRanks·09/24 14:30
Psychedelic: Optimi completes psilocybin production for Phase 2 trial
TipRanks·09/23 11:16
Canaccord Genuity Keeps Their Buy Rating on Helus Pharma (HELP)
TipRanks·09/22 21:34
Helus Pharma Shareholders Approve Name Change and Governance Resolutions
TipRanks·09/22 09:45
H.C. Wainwright Remains a Buy on Helus Pharma (HELP)
TipRanks·09/22 02:01
Helus Pharma’s CEO Makes Bold Insider Move Signaling Strong Confidence
Same Industry
Name/Symbol
Change%
Price